NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
Back to search
Official data from USPTO
AICHEMISTRY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AICHEMISTRY
ST13
US500000098387648Class
9, 42
Filing
98387648
Registration
8233356
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/28/2026
Trademark type
Word
Nice classes
9, 42
Filing date
02/01/2024
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/29/2023
First use in commerce
11/29/2023
Drawing code
4
Owner type
99
Owner location
Central, Hong Kong, HK
Examiner
LUCAS, PATRICK T
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Insilico Medicine IP Limited
Representatives
Jacqueline M. Lesser ICE MILLER LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software applications for estimating the relative binding free energy to prioritize molecules with efficient physics-based methods; downloadable and recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software platform for operating programs; data processing apparatus being data processors
Class 42
Technological research in the field of drug design and development and patent mapping; scientific research and development; scientific research and development relating to patent mapping; scientific research in the field of artificial intelligence for drug research and development; research and development of new products; research and development of new products for others; scientific laboratory servicesnamely laboratory services in drug design and development; cancer research for medical purposes; artificial intelligence consultancy in drug design and developmentchemistry servicesclinical trialsbiomedical research servicesmedical laboratory servicesmedical research services; drug research and development; design and development of computer software; custom design of computer software in the field of drug design and development; design and development of computer software for estimating the relative binding free energy to prioritize molecules with efficient physics-based methods; computer software installationmaintenance and repair; installation of computer software using artificial intelligence for automated machine learning in the field of drug design and development; development of computer platforms; research in computer natural language processing; design of computer-simulated models; software as a service (SAAS) services featuring software for using artificial intelligence for automated machine learning in the field of drug design and development; software development in the framework of software publishing; platform as a service (PAAS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of drug design and development; design and development of computer platforms; computer system design; computer programming servicesnamely natural language processing; computer programming servicesnamely creating and designing website-based indexes of information in the field of drug design and development for others using information technology
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/03/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/03/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/01/2025
DOCK
ASSIGNED TO EXAMINER
10/23/2025
IUAF
USE AMENDMENT FILED
06/06/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/06/2025
DOCK
ASSIGNED TO EXAMINER
04/25/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/10/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/13/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
10/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/03/2024
PUBO
PUBLISHED FOR OPPOSITION
09/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/26/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2024
GNRT
NON-FINAL ACTION E-MAILED
04/28/2024
CNRT
NON-FINAL ACTION WRITTEN
04/28/2024
DOCK
ASSIGNED TO EXAMINER
04/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2024
NWAP
NEW APPLICATION ENTERED
02/05/2024
Continuous trademark protection
Get notified about every new filing that threatens AICHEMISTRY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.